Introduction
Gastric cancer is considered as one of the most common causes of cancer-related deaths
and a significant public health issue despite decreasing trends in its incidence and
mortality.[[1]],[[2]],[[3]] Evidence of studies indicates that gastric cancer incidence varies in different
parts of the world.[[3]],[[4]],[[5]] Less than a century ago, gastric cancer was the most common cancer in the United
States. Over the last decade, gastric cancer is mostly prevalent cancer in Eastern
Asia, East Europe, and South America, whereas the lowest rates are reported in North
America and most parts of Africa. As such, the annual age-standardized gastric cancer
incidence rates per 100,000 in men are 65.9 in Korea versus 3.3 in Egypt.[[6]] According to Global Cancer Observatory (GLOBOCAN, 2018), gastric cancer is the
third-leading cause of cancer death worldwide, following lung and colorectal cancer
in overall mortality. Gastric cancer has the fifth highest incidence among cancers,
with 5.7% of all new cases attributable to the disease. Over a million, new cases
of gastric cancer are diagnosed worldwide annually.[[5]],[[6]]
Evidence indicates that gastric cancer is also one of the most behaviorally influenced
and thus preventable.[[5]],[[6]],[[7]] Gastric cancer may be subdivided into three distinct subtypes: proximal, diffuse,
and distal gastric cancer based on the histopathologic and anatomic criteria. Each
subtype is associated with a unique.[[7]] This uniqueness was facilitated by the multifactorial nature of gastric cancer,
which shows a complex interplay between genetics as well as lifestyle and environmental
factors.[[5]],[[6]],[[7]]
Although gastric cancer's etiology is a complex topic, the most important and well-studied
risk factors are Helicobacter pylori infections and host genetic factors, such as
a positive family history for gastric cancer and/or a pro-inflammatory genetic profile.
As such, the most recent study conducted at the National Cancer Center in South Korea
among 1676 persons with H. pylori infection who had a family history of gastric cancer
in first-degree relatives reported that H. pylori eradication treatment reduced the
risk of gastric cancer.[[8]],[[9]],[[10]] In addition, environment and nutrition are identified as the risk factors for gastric
cancer, including diet, body mass index, smoking, bacterial infections, and a variety
of occupational exposures, such as tin mining, metal processing, rubber manufacturing
industries, or ionizing radiation lead to an increased risk of gastric cancer.[[4]],[[9]],[[10]],[[11]]
Methods
The search of the literature was carried out using a combination of the following
search terms: “gastric cancer,” “risk factors,” “prevention,” “lifestyle,” “treatment,”
“prognosis,” “H. pilory,” “diet,” and “nutrition.” The search for eligible articles
was conducted through CINAHL, Medline/PubMed, Scopus, Cochrane, Emerald Insight, and
Web of Science scientific databases.
The inclusion criteria were English-language articles on the risk factors associated
with gastric cancer in humans, study year (1990–2020), study type, and access to the
full text of the studies. Based on the inclusion criteria checklist, as mentioned
above, studies that did not meet this list were excluded. Considering the available
data and literature, the authors present a summary of the main findings about the
risk factors associated with gastric cancer. In this review, we address the role of
important environmental risk factors in the onset of gastric cancer and highlight
the current treatment modalities and prevention measures.
Gastric Carcinogenesis
Evidence in research shows that gastric cancer is a result of the interaction of many
risk factors as well as protective factors, including genetic, environmental, unhealthy
nutrition, exogenous chemicals, intragastric synthesis of carcinogens, infectious
agents, host genetic, bacterial factors, as well as pathological conditions in the
stomach (such as gastritis).[[9]],[[10]],[[11]] The understanding of gastric carcinogenesis and prevention is largely based on
original articles published over the past three decades. One of the first publications
was Correa's multistep model of gastric carcinogenesis, which presents a well-accepted
general hypothesis.[[12]] In this hypothesis, a precancerous gastric process for the intestinal type is defined
as a multistep and multifactorial process, with the following sequential stages: chronic
gastritis, atrophy, intestinal metaplasia, and dysplasia.[[12]]
Helicobacter pylori
Since the discovery of H. pylori (1983), its close association with peptic ulcers
and gastric cancer has been documented in numerous studies. Although several prospective
case–control studies have attempted to evaluate the link between H. pylori infection
and gastric cancer development, results are inconsistent.[[13]],[[14]],[[15]] Based on the significant data from both control and cohort studies, H. pylori infection
is causally associated with gastric cancer in the populations of Japan and China.[[15]] Most H. pylori infections are acquired during childhood and once established, usually
persist for life unless treated. The prevalence of H. pylori infection in adults exceeds
50% in many industrialized countries. In 1994, the International Agency for Research
on Cancer classified H. pylori as a Class I carcinogen and reconfirmed this classification
in 2009.[[16]] Statistics from 2019 show that chronic infection with H. pylori is the leading
cause of gastric cancer, accounting for approximately 89% of distal gastric cancer
cases worldwide.[[16]]
H. pylori's identification as a risk factor for gastric carcinogenesis has stimulated
extensive research on the mechanisms by which H. pylori induces carcinogenesis.[[16]],[[17]],[[18]] Furthermore, it has been considered that human gastric carcinogenesis is a multistep
process whereby epithelial cells accumulate molecular alterations by genetic and epigenetic
mechanisms involving oncogenes, tumor-suppressor genes, DNA repair genes, cell cycle
regulators, and signaling molecules. Gastric cancer genetic basis studies, including
host genetic susceptibility, have shed considerable light on the pathogenesis of this
disease and have underscored the role of infection and chronic inflammation in gastric
cancer. As such, gastric cancer is an infection-induced, inflammation-driven malignancy,
developing after several decades among people with a genetic predisposition.[[16]],[[17]],[[18]]H. pylori is a genetically very diverse bacterium, and several genotypes have been
associated with virulence and risk of gastric disease, including vacAs 1, vcAm 1,
and cagA positive. CagA causes pathological changes that are closely associated with
the development of gastritis, gastric ulcer, and gastric cancer. CagA-positive strains
of H. pylori are more virulent, causing higher levels of inflammation of the gastric
mucosa in gastritis and gastric cancer.[[17]],[[18]]
The presence of H. pylori in the gastric mucosa can induce methylation of promoters
containing CpG islands by activating DNA methyltransferase. Besides, the aberrant
methylation of CpG islands is present along the multistep process of gastric carcinogenesis.[[4]],[[19]] In their study, Kim et al. reported that H. pylori infection promotes gastric carcinogenesis
by increasing endogenous DNA damage while decreasing repair activities and by inducing
mutations in the mitochondrial and nuclear DNA.[[20]] Hence, it may be concluded that the aberrant DNA methylation and other molecular
alterations observed in some genes induced by H. pylori infection are the significant
risk factors for gastric carcinogenesis.[[19]],[[20]]
Genetic factors
Research is increasingly looking at the role of host/human genetics in H. pylori-associated
gastrointestinal duodenal disease.[[21]],[[22]],[[23]],[[24]] Several single nucleotide polymorphisms in genes encoding a variety of inflammatory
mediators have apparent functional relevance since they influence cytokine bio-availability
or expression levels. This includes interleukin (IL)-1 β, potent pro-inflammatory
cytokine and inhibitor of gastric acid secretion. Thus, expression of IL-1B-511T and
IL-1RN *2 has been associated with a significant increase in the risk of gastric cancer.
While the L-C-T haplotype, including the wild-type IL-1RNL and IL-1B-511C alleles,
has been more often associated with the control group than with gastric cancer cases.[[21]],[[22]]
Major risk factors for gastric cancer include age, H. pylori, and Epstein-Barr virus
infection, race, gender, obesity, GERD, tobacco, alcohol, and family history. In addition
to nongenetic risk factors, about 10%–20% of gastric cancer patients show familial
aggregation of the disease, of which 2%–5% has been classified as hereditary.[[21]],[[22]],[[23]],[[24]] Three major familial gastric cancer syndromes have been described in existing data,
including hereditary diffuse gastric cancer (HDGC), familial intestinal cancer, and
gastric adenocarcinoma and proximal gastric polyposis of the stomach. The risk of
developing gastric cancer is high in families with these syndromes, but until recently,
only HDGC has been genetically explained. Thus, only one gene, E-cadherin (CDH1),
has been associated with hereditary gastric cancer, and 40% of HDGC cases carry CDH1
mutations. However, recent advances in high-throughput DNA analysis identified the
several regions of the genome associated with an increased risk of gastric cancer.[[21]],[[22]],[[23]],[[24]]
Thus, there is evidence for a causal role for PALB2 (gene for breast and pancreatic
cancer) and other genes involved in homologous recombination DNA repair in gastric
cancer risk. Gastric cancer has also been reported in cancer syndromes such as lynch
syndrome, Li-Fraumeni syndrome, juvenile polyposis syndrome, Peitz-Jeghers syndrome,
and hereditary breast and ovarian cancer syndrome.[[23]],[[24]]
Dietary factors
Before the discovery of H. pylori (1983), epidemiological studies already suggested
the critical role of lifestyle in the etiology of gastric cancer. Probably, the best-established
associations are the links between cancer risk and diets that contain excessive salt
intake and low consumption of fresh fruits and vegetables.[[25]] Studies conducted in 2013 reported that the incidence of gastric cancer has decreased
over the past few decades in most European countries, which is thought to reflect
mainly lifestyle and environmental changes such as smoking cessation and H. pylori
eradication.[[25]] Thus, factors other than H. pylori have been implicated in the incidence of gastric
cancer. Daily consumption high-salt foods significantly increase the risk of gastric
cancer. Processed meat was found to significantly increase the risk of noncardia gastric
cancer, while obesity was associated with a higher risk of stomach cardia cancer.[[7]],[[25]]
The acute effects of concentrated salt liquids lead to mucosal damage, and its repair
is associated with inflammatory changes in the human stomach.[[11]],[[12]] In China, Kneller et al. studied the relationship between the mortality rate from
gastric cancer and the results of a study on diet, lifestyle, and biochemical markers.
The authors found a significant positive association between the consumption of salted
vegetables and eggs and the mortality rate from stomach cancer.[[26]]
Furthermore, studies have been conducted to evaluate the association of nitrates,
nitrites, and N-nitroso compounds with gastric cancer. Salt ingestion has been shown
to enhance gastritis and carcinogenic effects of known gastric carcinogens such as
N-methyl-N-nitro-N-nitrosoguanidine.[[26]],[[27]],[[28]] Those societies whose diets are rich in salty and canned foods, such as the Japanese,
report higher levels of gastric cancer. Furthermore, canned meat, vegetables and fish
rich in N-nitroso compounds cause a similar effect in the body. Red meat fed with
the grain is especially rich in saturated fats and contains few protective fats, such
as omega-3, which contributes to its inflammatory processes and thus, increases the
risk of gastric cancer.[[26]],[[27]],[[28]] Several case-control studies in Europe, Asia, and North America have continually
reported that consuming fresh fruits and vegetables protect against gastric cancer,
reducing the risk by about 40% with the consumption of fruits and 30% with vegetables.[[29]],[[30]] Populations at high risk of developing gastric cancer were shown to consume food
rich in starch and low protein and are not prone to eat fresh fruits and vegetables.
Hence, diets with both high starch and low protein can promote acid-catalyzed nitrosation
in the stomach and cause mechanical damage to the gastric mucosa.[[29]],[[30]],[[31]] According to a report by the World Cancer Research Fund/American Institute for
Cancer Research (WCRF, 2018) on dietary factors and cancer prevention stated that
nonstarchy vegetables and fruits probably protect against gastric cancer.[[31]] Data from experimental and animal studies indicate several potential mechanisms
by which Vitamin C may affect gastric carcinogenesis. Vitamin C reduces gastric mucosal
oxidative stress and DNA damage, and gastric inflammation by scavenging reactive oxygen
species. It inhibits gastric nitrosation reaction for the formation of N-nitroso compounds
by reducing nitrous acid to nitric oxide and producing dehydro-ascorbic acid in the
stomach; it enhances host immunologic functions; it has a direct effect on H. pylori
growth and virulence, and it inhibits gastric cell proliferation and induces apoptosis.[[30]],[[31]],[[32]]
Lifestyle factors
Additional risk factors for developing gastric cancer are drinking alcohol and smoking
tobacco. In 2008, a meta-analysis of 42 studies showed that smokers increased the
risk of stomach cancer by about 1.53 times and was higher in men than in women. According
to the WCRF, an estimated 11% of stomach cancer cases in the world and 17% of cases
in Europe were related to smoking.[[7]],[[16]],[[25]] Furthermore, the European Prospective Investigation into Cancer and Nutrition project
found a significant association between the intensity and duration of cigarette smoking
and gastric cancer risk.[[33]] In Japan, a population-based prospective study of the combined influence of cigarette
smoking and H. pylori infection indicated that approximately 28.4% of gastric cancers
are related to cigarette smoking.[[34]] The relative risk for gastric cancer increases with rising frequency and amount
of alcohol consumed. Those who tend to drink alcohol at least once a week have three
times higher risk for gastric cancer than nondrinkers.[[35]]
The association between cigarette smoking and gastric cancer has been investigated
in a number of epidemiologic studies, including both case-control and cohort studies,
but the results are inconsistent.[[35]],[[36]] However, recently new studies have confirmed the direct correlation between the
consumption of alcohol and tobacco and the risk of gastric cancer. Smoking was associated
with a risk of stomach cancer for both former smokers and current smokers, with current
smokers posing a higher risk than former smokers. In Japan, approximately 28.4% of
gastric cancers are related to cigarette smoking, according to data from the Hisayama
Study, a population-based prospective study of the combined influence of cigarette
smoking and H. pylori infection and confirmed that cigarette smoking is significantly
associated with increased risk of gastric cancer independent of H. pylori infection.[[35]],[[36]]
Prevention and high-quality treatment can dramatically improve the poor prognosis
of gastric cancer. A key factor in designing prevention strategies is the distinction
of the general population and individuals into high, intermediate, and low-risk categories
for developing gastric cancer.[[35]],[[36]],[[37]]
Prevention and Treatment
In all populations and countries, gastric cancer is uniformly rare in adults aged
<50 years. Gastric cancer incidence rates increase with increasing age and reach a
plateau between 55 and 80 years. On average, the incidence rates for gastric cancer
are 2-fold to 3-fold higher for men than women. Several countries, including Venezuela,
Chile, Korea, China, and Japan, have implemented various screening programs.[[38]] Gastric cancer prevention has focused on screening and surveillance as well as
H. pylori screening and eradication. The potential effectiveness of a gastric cancer
prevention program that includes H. pylori screening and treatment is dependent upon
a patient's level of cancer risk at the time H. pylori is eradicated (e.g., considering
the 2-fold higher risk of developing gastric cancer between the most-and the least-virulent
strains) and the screening modality used. Under various assumptions about both effectiveness
and costs, population-based screening for H. pylori and eradication of the infection
has been shown to be cost-effective.[[16]],[[17]],[[18]],[[38]]
The strong causal link between H. pylori and gastric cancer presents a unique opportunity
for considering antibiotic eradication treatment as a chemo preventive strategy against
a neoplastic disease. Current evidence suggests that, in a subpopulation of the treated
subjects, H. pylori eradication prevents the progression of preneoplastic lesions.[[9]] As was shown in a randomized trial involving first-degree relatives of gastric
cancer patients, the risk of gastric cancer was 55% lower among those who received
H. pylori eradication treatment than among those who received a placebo during a median
follow-up of 9.2 years. Whereas the risk of gastric cancer was 73% lower among persons
in whom H. pylori eradication was achieved than among those in whom infection was
persistent.[[10]],[[38]],[[39]] A meta-analysis of six randomized trials, including healthy, asymptomatic participants
with H. pylori infection, reported that the risk of gastric cancer was approximately
34% lower among those who received treatment than among those in the control groups.[[10]],[[38]],[[39]]
Diet and nutritional chemoprevention is the ideal strategies proposed for the prevention
of gastric cancer, considering the role of diet in the etiology of the disease. The
chemoprevention approach involves using specific natural or synthetic chemical agents
to reverse, suppress, or prevent premalignancy from progressing to invasive cancer.[[28]],[[39]] It is essential to test the chemo preventive efficacy of a putative agent in gastric
carcinogenesis in an animal model before embarking on clinical trials.[[38]],[[39]]
Gastric cancer remains difficult to cure. Prognosis depends on the stage at which
it is detected, and complete surgical resection remains the only curative modality
for early-stage gastric cancer. Early gastric cancer may be treated with surgery,
usually followed by chemotherapy or combined chemo-and radiotherapy. Although surgery,
including gastrectomy in combination with systemic lymph node dissection, is the current
treatment of choice for gastric cancer, laparoscopy-assisted distal gastrectomy (LADG)
is widely accepted surgery for early gastric cancer in recent years. The practice
of LADG for early stage of gastric cancer is considered a first-line additional therapy
after endoscopic resection in Japan.[[40]]
In some cases where surgical resect ability is doubtful in the initial presentation,
neo-adjuvant chemotherapy is preferred. Several trials proved the survival benefit
from combined modality therapy.[[37]],[[38]],[[39]],[[40]] Surgical resection with regional lymphadenectomy is the treatment of choice for
patients with stage II gastric cancer. According to the new American Joint Committee
on Cancer 7th ed.ition, tumor-nodal-metastasis staging classification, gastric cancer
Stage II is an intermediate stage between Stage I and Stage III. However, preoperative
and intraoperative staging to confirm Stage II disease is complicated. The degree
of surgical resection depends on the histopathological outcome. A multidisciplinary
method for the planning of gastric cancer treatment is necessary. The multidisciplinary
team should include at least a surgeon, pathologist, gastroenterologist, medical,
and radiation oncologists. The treatment depends on the stage of the disease.[[19]],[[37]],[[38]],[[39]],[[40]]
